News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|March 16, 2021

Discussing obesity and eating disorders with patients and families

Author(s)Miranda Hester

Andrew J. Schuman, MD, FAAP, discusses talking with patients and their families about a variety of nutrition topics including eating disorders and obesity.

Promoting healthy habits in a nutrition is an important element in setting a child on the path of optimal health outcomes.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Artificial sweeteners show mixed effects on diabetes management | Image Credit: © Proxima Studio - stock.adobe.com.

Artificial sweeteners show mixed effects on diabetes management

ByMorgan Ebert, Managing Editor

November 2nd 2025

Simple interventions improve pediatrician adherence to peanut allergy prevention guidelines | Image Credit: © Stepan Popov - stock.adobe.com.

Simple interventions improve pediatrician adherence to peanut allergy prevention guidelines

ByMorgan Ebert, Managing Editor

October 7th 2025

Embedding food outreach specialists in pediatric clinics connects families with resources | Image Credit: © Kittiphan - stock.adobe.com.

Embedding food outreach specialists in pediatric clinics connects families with resources

ByMorgan Ebert, Managing Editor

September 27th 2025

Guideline introduces recommendations for postoperative nutrition in neonates with enterostomy | Image Credit: © Prostock-studio - stock.adobe.com.

Guideline introduces recommendations for postoperative nutrition in neonates with enterostomy

ByMorgan Ebert, Managing Editor

September 4th 2025

Family socioeconomic position linked to eating disorder symptoms in adolescence | Image Credit: © VectorMine - stock.adobe.com.

Family socioeconomic position linked to eating disorder symptoms in adolescence

ByMorgan Ebert, Managing Editor

August 29th 2025

Latest CME

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

FDA approves first gene replacement therapy (Itvisma) for patients 2 years and older with spinal muscular atrophy

Otsuka submits centanafadine NDA to FDA to treat ADHD in children, adolescents, adults

Druhan Howell, MD, discusses ACAAI tapinarof data for pediatric atopic dermatitis

Jonathan Flyer, MD, highlights the LEAD initiative to increase pediatric lipid screenings

Ruxolitinib Efficacy and Safety in Pediatric AD

© 2025 MJH Life Sciences^®

All rights reserved.